Peptide Encyclopaedia
ACTH (1–39)
Also known as Corticotropin, Adrenocorticotropic hormone.
Approved-medicine listing only. This is not available from the Cellular Sequence shop. Licensed products require a prescriber and an ARTG-registered presentation.
At-a-glance profile
- Classification
- Pituitary tropic peptide hormone
- Approval status
- Approved medicine
- Research status
- Labelled indications are defined in product information.
- Molecular formula
- Insufficient reliable evidence identified.
- Molecular weight
- Insufficient reliable evidence identified.
- Sequence
- 39-residue ACTH; diagnostic analogues (e.g. tetracosactide) are licensed separately.
- Primary biological target
- Insufficient reliable evidence identified.
- Half-life
- Insufficient reliable evidence identified.
- Routes investigated
- Insufficient reliable evidence identified.
- Human evidence level
- A — Approved clinical use / strong human evidence
What is it?
A hormone that drives adrenal cortisol. Research ‘ACTH 1-39’ vials are not Synacthen tests.
Mechanism of action
MC2 receptor agonism on the adrenal cortex.
Acute steroidogenesis; chronic excess is Cushing-like.
What is it being studied for?
- Adrenal diagnostic testing
- Selected inflammatory protocols historically
Investigational findings are not proven clinical benefits unless an authority has labelled that indication.
Evidence level
Overall human evidence grade: A · Approved clinical use / strong human evidence
Human research
Licensed corticotropin analogues exist; catalogue ACTH is not equivalent.
Preclinical research
Animal, cell and in-vitro findings are listed separately from human effects.
Classic pituitary–adrenal axis.
Doses reported in published research
This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.
Doses reported in human studies
Insufficient reliable evidence identified.
Preclinical / animal study dosing
Insufficient reliable evidence identified.
Pharmacokinetics
Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.
Safety
Hypertension, hyperglycaemia, infection risk, mood change if bioactive.
Unknowns. Absence of a published harm signal is not evidence of safety.
Contraindications. Systemic steroid-axis drugs require specialist oversight.
Regulatory status
Approved as specific diagnostic/therapeutic presentations.
Cellular Sequence does not sell this as a vial, tablet, oil, or injectable. Educational encyclopaedia listing only.
Citations
[1] Encyclopaedia note
Encyclopaedia note
For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.
Last reviewed 2026-09-13. Research areas: Metabolic, Healthy Ageing · Compare peptides